Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis

Nature

Volumn 456, Issue 7223, 2008, Pages 814-819

  Stockmann, Christian ^a   Doedens, Andrew ^a   Weidemann, Alexander ^a   Zhang, Na ^a   Takeda, Norihiko ^a   Greenberg, Joshua I ^b   Cheresh, David A ^c   Johnson, Randall S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

CELL ORGANELLE; CHEMOTHERAPY; CYTOCHROME; GROWTH RESPONSE; HYPOXIA; RODENT; TUMOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CARCINOGENESIS; CELL INFILTRATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; TRANSGENIC MOUSE; TUMOR CELL DESTRUCTION; TUMOR GROWTH;

ANIMALS; ANOXIA; ANTINEOPLASTIC AGENTS, ALKYLATING; CARCINOMA; CYTOTOXINS; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 57649112725     PISSN: 00280836     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/nature07445     Document Type: Article

References (12)

1. Folkman, J. Angiogenesis. Annu. Rev. Med. 57, 1-18 (2006).
2. Lewis, J. S., Landers, R. J., Underwood, J. C., Harris, A. L. & Lewis, C. E. Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J. Pathol. 192, 150-158 (2000).
3. Gerber, H. et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nature Med. 5, 623-628 (1999).
4. Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R. & Forster, I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265-277 (1999).
5. Cramer, T. et al. HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112, 645-657 (2003).
6. Guy, C. T., Cardiff, R. D. & Muller, W. J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12, 954-961 (1992).
7. Lin, E. Y. et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am. J. Pathol. 163, 2113-2126 (2003).
8. Grunstein, J., Roberts, W. G., Mathieu-Costello, O., Hanahan, D. & Johnson, R. S. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function. Cancer Res. 59, 1592-1598 (1999).
9. Lin, E. Y. et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 66, 11238-11246 (2006).
10. Mayer, E. L., Lin, N. U. & Burstein, H. J. Novel approaches to advanced breast cancer: bevacizumab and lapatinib. J. Natl. Compr. Canc. Netw. 5, 314-323 (2007).
11. Hurwitz, H. I., Honeycutt, W., Haley, S. & Favaro, J. Long-term treatment with bevacizumab for patients with metastatic colorectal cancer: case report. Clin. Colorectal Cancer 6, 66-69 (2006).
12. Gerber, H. P. et al. VEGF is required for growth and survival in neonatal mice. Development 126, 1149-1159 (1999).